drugset / Trial / NCT05655819
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this research is to collect data from patients diagnosed with functional dyspepsia who are treated with glutamine and describe safety and treatment results compared to patients taking a placebo. Glutamine, an essential amino acid in humans, is an important energy source for cells lining the gastrointestinal tract and has been shown to play an important role in regulating the strength of the intestinal wall.
Timeline
- Start
- 2023-02-16
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glutamine | Other / unclassified | 5 g | Oral |